Type 1 Diabetes, Exercise and Mentoring Trial

NCT06296992 · tracked via the Priya Life Science Canada tracker

Sponsor

University of Manitoba

Phase

Not applicable

Started

2025-02-01

Last updated

2026-06-01

Condition(s) studied

Type 1 DiabetesPhysical Activity

Investigational drug(s) / intervention(s)

12-week TEAM peer mentor program

12-week TEAM peer mentor program: A 12-week peer-led behavioural intervention that supports increased physical activity. It will consist of 3 weekly contacts between participants and peer mentors that will be a mix of in-person, virtual, and texting. The intervention components and communication between adolescents and peer mentors with T1D will be guided by SDT, and designed to overcome the key psychosocial barriers to PA. The peer mentors that complete the training will deliver a 12-week intervention to increase behavioural skills that foster autonomy for goal setting and overcoming barriers to PA.

Study summary

The proposed study aims to improve the psychosocial health of adolescents living with type 1 diabetes (T1D). The study will generate knowledge and support knowledge mobilization about the effectiveness of a novel model of care for psychosocial health and self-management for adolescents living with type 1 diabetes (T1D). The novel model of care is the recruitment and training if young adult mentors to deliver a behavioural intervention that empowers adolescents with T1D to increase daily physical activity. The study will also advance the development and implementation of this peer mentoring model to improve the psychosocial health of adolescents with T1D.

Eligibility

Sex

ALL

Min age

13 Years

Max age

17 Years

Healthy volunteers

Inclusion Criteria: * want to increase their daily PA * currently use a continuous glucose monitor (CGM) Exclusion Criteria: * were diagnosed with T1D within 12 months of randomization * have diabetes secondary to medications or surgery * have cancer * evidence of drug/alcohol abuse * have an eating disorder * an orthopedic injury or illness that would limit their ability to engage in daily PA * a suicide attempt in the previous 12 months * are pregnant

Primary outcome measure(s)

Enrollment rates — during the study period of approximately three years.
Defined as the number of (i) adolescents who consent to participate and are randomized to one of the two study arms during the study period of approximately three years and (ii) the number of young adults who agree and complete the training to become peer mentors to the adolescents during the study period of approximately three years.
Adherence to the intervention arms — during the study period of approximately three years
Defined as the percentage of prescribed sessions that adolescents attended during the trial period of approximately three years
Retention for follow-up measurements — during the study period of approximately three years.
Defined as the percentage of adolescents who complete follow-up measurements during the study period of approximately three years.

Trial sites (2)

Facility	City	Region	Status
the Children's Hospital Research Institute of Manitoba and the University of Manitoba	Winnipeg	Manitoba	Recruiting
Trillium Health Partners	Mississauga	Ontario	Recruiting

More University of Manitoba trials in Canada

Development and Online Evaluation of an Online Course for Parasomnias Recruiting

Effects of Peripheral Repetitive Peripheral Magnetic Stimulation on Individuals With Elbow or Wrist Chronic Pain Recruiting

A Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries Recruiting

Longitudinal Study to Investigate Different Transcranial Electrical Stimulation Recruiting

Management of CSDH With or Without EMMA- a Randomized Control Trial Active, not recruiting

Other trials for the same condition

A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight Active, not recruiting

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant Recruiting

Parents and Children Active Together Study Recruiting

Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide Recruiting

A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06296992 on ClinicalTrials.gov ↗ ← All trials in Canada